At the Retina Society meeting held in Chicago, Illinois, Christine N. Kay, MD a vitreoretinal surgeon and IRD specialist from Gainesville, Florida, presented research on MCO-010, a novel optogenetic ...
Hear highlights from the Vit-Buckle Society and its presence at EURETINA 2025. Maria Berrocal, MD, met up with Modern Retina® during the 2025 European Society of Retina Specialists (EURETINA) congress ...
ISTH0036 demonstrates potential to prevent fibrosis, reduce retinal fluid, and improve vision in AMD and diabetic macular edema patients. Marion Munk, MD, PhD, talked with Modern Retina® during the ...
EURETINA's 25th anniversary meeting attracts 11,000 participants, showcasing cutting-edge research and fostering global networking among retina specialists. The 2025 European Society of Retina ...
The submission was based on the safety and efficacy data from the phase 3 (RHODOS) and phase 4 (LEROS) studies. The US Food and Drug Administration (FDA) has granted Priority Review to Chiesi Global ...
Luxa Biotechnology reveals promising phase 1/2a trial results for RPESC-RPE therapy, showing safety and potential vision restoration in patients with dry AMD. Luxa is a clinical-stage biotechnology ...
The window shop provision in the Alcon merger agreement enabled STAAR to accept a competing acquisition proposal and terminate the Alcon merger. STAAR Surgical announced the expiration of the 45-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback